Pulse Biosciences (PLSE) Income towards Parent Company (2015 - 2025)

Pulse Biosciences' Income towards Parent Company history runs 11 years deep, the most recent figure standing at -$30.0 million for Q3 2025.

• On a quarterly basis, Income towards Parent Company fell 136.29% year-over-year to -$30.0 million in Q3 2025; TTM through Dec 2025 was -$65.9 million, a 222.99% decrease from a year earlier, with the FY2025 full-year figure at $72.8 million, up 35.82% from the prior year.
• Income towards Parent Company retreated to -$30.0 million in Q3 2025 per PLSE's latest filing, from -$19.2 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $87.8 million in Q4 2024 and bottomed at -$30.0 million in Q3 2025.
• The 5-year median for Income towards Parent Company is -$14.0 million (2022), against an average of -$9.7 million.
• Across the five-year window, Income towards Parent Company jumped 835.77% in 2024 and slumped 136.29% in 2025, its largest moves.
• Year by year, Income towards Parent Company stood at -$15.5 million in 2021, then soared by 40.52% to -$9.2 million in 2022, then retreated by 29.75% to -$11.9 million in 2023, then soared by 835.77% to $87.8 million in 2024, then tumbled by 134.12% to -$30.0 million in 2025.
• Per Business Quant, the three latest PLSE Income towards Parent Company figures stand at -$30.0 million (Q3 2025), -$19.2 million (Q2 2025), and -$16.8 million (Q1 2025).